On March 1, 2011, the World Health Organization certified that the SFDA’s standards meet international criteria for vaccine supervision. Other regulatory hurdles remain, but the WHO imprimatur means China vaccine makers will eventually be able to supply vaccines to resource-poor nations through UN-related agencies, a huge market. Over time, the WHO action could transform China’s vaccine industry. More details....

Share this with colleagues: